Company Growth (employees)
AbbVie was founded in 2013 and is headquartered in North Chicago, US
Key People/Management at AbbVie
Richard A. Gonzalez
Chairman of the Board and Chief Executive Officer
AbbVie Office Locations
AbbVie has an office in North Chicago
North Chicago, US (HQ)
1 Waukegan Rd
AbbVie Financials and Metrics
AbbVie Financials
AbbVie's revenue was reported to be $25.6 b in FY, 2016 which is a 12% increase from the previous period.
USD
Revenue (FY, 2016) | 25.6 b |
Revenue growth (FY, 2015 - FY, 2016), % | 12% |
Gross profit (FY, 2016) | 19.8 b |
Gross profit margin (FY, 2016), % | 77% |
Net income (FY, 2016) | 6 b |
Market capitalization (17-Oct-2017) | 147.5 b |
Cash (31-Dec-2016) | 5.1 b |
EV | 179.2 b |
AbbVie's current market capitalization is $147.5 b.
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 18.8 b | 20 b | 22.9 b | 25.6 b |
Revenue growth, % | 6% | 15% | 12% | |
Cost of goods sold | 4.6 b | 4.4 b | 4.5 b | 5.8 b |
Gross profit | 14.2 b | 15.5 b | 18.4 b | 19.8 b |
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 9.6 b | 8.3 b | 8.4 b | 5.1 b |
Accounts Receivable | 3.9 b | 3.7 b | 4.7 b | 4.8 b |
Inventories | 1.2 b | 1.1 b | 1.7 b | 1.4 b |
Current Assets | 17.8 b | 16.1 b | 16.3 b | 16.2 b |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 4.1 b | 1.8 b | 5.1 b | 6 b |
Accounts Receivable | 681 m | (172 m) | (1.1 b) | (71 m) |
Inventories | (56 m) | (203 m) | (434 m) | (38 m) |
Accounts Payable | (426 m) | (193 m) | 1.5 b | (1.2 b) |
| USD | Y, 2016 |
|---|---|
EV/CFO | 25.4 x |
Revenue/Employee | 1 m |
Debt/Equity | 7.9 x |
Debt/Assets | 0.6 x |
Financial Leverage | 14.3 x |
AbbVie Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| Stem CentRx | April 28, 2016 | $5.8 b |
AbbVie Market Value History
AbbVie Median Salaries
Source: 442 public H-1B filings from AbbVie
Market Position of AbbVie
Traffic Overview of AbbVie
AbbVie Online and Social Media Presence
AbbVie News and Updates
October 16, 2017
Merck targets high-risk military veterans for hepatitis C lessons
Veterans are three times more likely to have hepatitis C than the general population—and antiviral drugmaker Merck & Co. wants to make sure they know that.
October 13, 2017
Salivary Gland Infection Market Estimated to Witness a Staggering Growth of USD 3622.6 Million by 2023
Global salivary gland infection market information, by diagnosis (plain radiography, sialography), by treatment, by end user- Forecast till 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
October 13, 2017
NIH partners with biopharma to speed development of cancer immunotherapy work
The Partnership for Accelerating Cancer Therapies - PACT - is a five-year, $215 million collaboration and part of the Cancer Moonshot.
October 10, 2017
Biologics Market 2017 Accrues Vivaciously By 2027
Global Biologics Information, by Product type (vaccines, blood and blood products, allergenic extracts, human cells and tissues, proteins and others), by applications (Rheumatoid arthritis, Renal failure, Anemia, Cancer, Diabetes and others), by source (Humans, Avian Cell Culture, Yeast, Bacteria, I…
October 09, 2017
What's new on pharma's worry list? Cybersecurity, natural disasters and much more
Accounting and advisory firm BDO sifted through SEC filings to discover just what the top 100 life sciences companies are most worried about these days.
October 06, 2017
AbbVie hit with $140M verdict in second bellwether AndroGel case
A jury slapped AbbVie with a $140 million verdict in the second AndroGel case to reach a trial.